Key terms

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AUPH news

Apr 16 11:38am ET Aurinia Pharmaceuticals to Present at Investor Conference by TipRanks Apr 15 6:38am ET Aurinia Pharmaceuticals Announces Q1 Results Date by TipRanks Apr 09 6:37am ET Aurinia Pharma to Connect at Healthcare Investor Event by TipRanks Mar 01 11:55am ET Aurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS Prospects by TipRanks Feb 29 4:23pm ET Aurinia Pharmaceuticals Announces Executive R&D Leadership Change by TipRanks Feb 29 9:18am ET Aurinia Pharmaceuticals Launches Share Buyback Plan by TipRanks Feb 27 9:09am ET Aurinia Pharmaceuticals Engages Investors at March Conferences by TipRanks Feb 22 6:30am ET Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN) and Aurinia Pharmaceuticals (AUPH) by TipRanks Feb 22 6:13am ET H.C. Wainwright cuts Aurinia target, says 28% selloff overdone by TipRanks Feb 20 12:45pm ET Aurinia Pharmaceuticals call volume above normal and directionally bullish by TipRanks Feb 18 11:47pm ET Aurinia Pharmaceuticals: A Buy Rating on Strong Lupkynis Sales and Streamlined Operations by TipRanks Feb 16 1:02am ET New Corporate Activity and Growth Risk for Aurinia Pharmaceuticals – What’s the Latest? by TipRanks Feb 15 12:20pm ET Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Aurinia Pharmaceuticals (AUPH) by TipRanks Feb 15 6:22am ET Aurinia Pharmaceuticals Announces Strategic Review Outcomes and Buyback Program by TipRanks Feb 15 6:19am ET Aurinia Pharmaceuticals sees 2024 revenue $200M-$220M, consensus $217.87M by TipRanks Feb 15 6:16am ET Aurinia Pharmaceuticals reports Q4 EPS (19c), consensus (16c) by TipRanks Jan 18 11:25am ET Aurinia Pharmaceuticals call volume above normal and directionally bullish by TipRanks

No recent press releases are available for AUPH

AUPH Financials

1-year income & revenue

Key terms

AUPH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AUPH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days